Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigator?s Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor ARPI, in Participants with Metastatic Castration-resistant Prostate Cancer mCRPC - rechARge
Study Type: Treatment
Phase: III
NCTID: NCT06764485
Principal Investigator:
Haoran Li
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen
ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide
Study Type: Treatment
Phase: II
NCTID: NCT04335682
Principal Investigator:
Elizabeth Wulff-Burchfield
Weight management Aimed to Reduce Risk and Improve Outcomes from Radical Prostatectomy: WARRIOR
Study Type: Basic Science
Phase: N/A
NCTID: NCT03261271
Principal Investigator:
Jill Hamilton-Reeves
A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer mCRPC
Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
A Phase III, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT04566588
Principal Investigator:
Kerri Thurmon
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Study Type: Health Services
Phase: III
NCTID: NCT03860961
Principal Investigator:
Ronald Chen